Preclinical News and Research

RSS
Patrys provides update on development programme for anti-cancer product, PAT-LM1

Patrys provides update on development programme for anti-cancer product, PAT-LM1

Researchers developing new medication to tackle river blindness and elephantiasis

Researchers developing new medication to tackle river blindness and elephantiasis

GHIT Fund announces grants to speed up innovative drug development for neglected diseases

GHIT Fund announces grants to speed up innovative drug development for neglected diseases

LSTM and University of Liverpool receive GHIT Fund to target lymphatic filariasis and onchocerciasis

LSTM and University of Liverpool receive GHIT Fund to target lymphatic filariasis and onchocerciasis

New data shows curative effects of GFT505 in NASH associated with metabolic disorders

New data shows curative effects of GFT505 in NASH associated with metabolic disorders

Systemic stem cell therapy reduces malignant mesothelioma growth

Systemic stem cell therapy reduces malignant mesothelioma growth

Igenica Biotherapeutics doses first patient in Phase 1 clinical trial of IGN523 in patients with AML

Igenica Biotherapeutics doses first patient in Phase 1 clinical trial of IGN523 in patients with AML

Non-alcoholic steatohepatitis (NASH): an interview with Jean-François Mouney, CEO of Genfit

Non-alcoholic steatohepatitis (NASH): an interview with Jean-François Mouney, CEO of Genfit

People who experience chronic sleep disturbance could face earlier onset of dementia, Alzheimer's

People who experience chronic sleep disturbance could face earlier onset of dementia, Alzheimer's

Cytoplasmic HIF-2α linked to poor prognosis in renal cell carcinoma

Cytoplasmic HIF-2α linked to poor prognosis in renal cell carcinoma

Antibe Therapeutics completes pre-clinical program for its lead product ATB-346

Antibe Therapeutics completes pre-clinical program for its lead product ATB-346

Adherent stromal cells derived from human placenta improve tendon healing, shows study

Adherent stromal cells derived from human placenta improve tendon healing, shows study

Derma Sciences' net sales increase 3% to $20.7 million in fourth quarter 2013

Derma Sciences' net sales increase 3% to $20.7 million in fourth quarter 2013

UC Davis MIND Institute named Intellectual and Developmental Disabilities Research Center

UC Davis MIND Institute named Intellectual and Developmental Disabilities Research Center

CNIO scientist wins 2014 Stewart Rahr-PCF Young Investigator Award from Prostate Cancer Foundation

CNIO scientist wins 2014 Stewart Rahr-PCF Young Investigator Award from Prostate Cancer Foundation

AnaptysBio announces strategic immuno-oncology collaboration with TESARO

AnaptysBio announces strategic immuno-oncology collaboration with TESARO

SAGE Therapeutics announces completion of $38 million Series C financing

SAGE Therapeutics announces completion of $38 million Series C financing

Aradigm reports record revenue of $4.6M in fourth quarter 2013

Aradigm reports record revenue of $4.6M in fourth quarter 2013

Knopp and NIAID collaborate to investigate eosinophil-lowering effects of dexpramipexole

Knopp and NIAID collaborate to investigate eosinophil-lowering effects of dexpramipexole

CRO services division of Galapagos to be acquired by Charles River Laboratories

CRO services division of Galapagos to be acquired by Charles River Laboratories

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.